Should brachytherapy be considered a therapeutic option in localized prostate cancer?

The Urologic Clinics of North America
J C BlaskoP D Grimm

Abstract

Contemporary prostate brachytherapy incorporates advances in computer analysis, imaging technology, and delivery apparatus, allowing exacting and reproducible results compared with historical approaches. The advances permit brachytherapy to be performed on a cost-effective, outpatient basis with low morbidity in the appropriately selected patient. Although unsettled questions remain regarding dosimetric issues, long-term outcomes, and morbidity, the weight of evidence to date appears to support the use of brachytherapy in selected patients. Brachytherapy may be considered a therapeutic option: as monotherapy for early-stage disease and also a boost following moderate doses of external beam irradiation for locally advanced disease.

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·D A KubanP Schellhammer
Feb 1, 1992·British Journal of Urology·J AdolfssonT Löwhagen
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·K KhanC Stidley
Apr 22, 1992·JAMA : the Journal of the American Medical Association·J E JohanssonU B Krusemo
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M S PorrazzoN Salvaras
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·C D KoprowskiL W Brady
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J D Morton, R E Peschel
Dec 1, 1988·International Journal of Radiation Oncology, Biology, Physics·G E HanksJ J Diamond
Oct 1, 1986·International Journal of Radiation Oncology, Biology, Physics·T F DeLaneyG R Prout
Dec 1, 1986·International Journal of Radiation Oncology, Biology, Physics·G M Giles, L W Brady
Feb 2, 1994·JAMA : the Journal of the American Medical Association·J I EpsteinC B Brendler
Sep 30, 1994·International Journal of Radiation Oncology, Biology, Physics·K WallnerL Harrison
Feb 1, 1993·Cancer·F K MostofiC J Davis
Apr 30, 1995·International Journal of Radiation Oncology, Biology, Physics·R G StockJ K DeWyngaert
Sep 30, 1994·International Journal of Radiation Oncology, Biology, Physics·J CrookB Esche
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·K WallnerL Harrison
Jun 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J D FormanA T Porter
Nov 15, 1993·International Journal of Radiation Oncology, Biology, Physics·H M SandlerA S Lichter
Jan 1, 1994·International Journal of Radiation Oncology, Biology, Physics·B R PrestidgeM A Bagshaw
Mar 15, 1993·International Journal of Radiation Oncology, Biology, Physics·V E ArterberyZ Fuks
Apr 30, 1993·International Journal of Radiation Oncology, Biology, Physics·J N RoyL L Anderson

❮ Previous
Next ❯

Citations

Jul 27, 1999·The Prostate·N J HegartyD S Coffey
Jan 9, 2001·CA: a Cancer Journal for Clinicians·H RagdeA A Elgamal
May 21, 2003·Current Urology Reports·Harrie P Beerlage
Dec 20, 1999·Seminars in Roentgenology·S R Potter, A W Partin
Mar 4, 2000·Urology·J C Blasko
Dec 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J Battermann
Dec 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J C BlaskoW Cavanagh
Apr 5, 2001·International Journal of Radiation Oncology, Biology, Physics·R J EllisT J Kinsella
May 31, 2001·International Journal of Radiation Oncology, Biology, Physics·K M SnyderN N Stone
Jun 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Eva K Lee, Marco Zaider
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·T P MateL Van Hollebeke
Dec 30, 1998·International Journal of Radiation Oncology, Biology, Physics·E M TapenT W Griffin
May 29, 1999·International Journal of Radiation Oncology, Biology, Physics·F A ViciniA Martinez
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·J C BlaskoW Cavanagh
Mar 22, 2000·International Journal of Radiation Oncology, Biology, Physics·N N Stone, R G Stock
Feb 19, 2003·Medical Engineering & Physics·R Lefrançois, R S Sloboda
May 10, 2006·Prostate Cancer and Prostatic Diseases·P L AcherR P Beaney
Jul 26, 2000·Journal of Endourology·A J Chan, B Saltzman
Nov 12, 1998·Plastic and Reconstructive Surgery·S A TrottK W Klein
Feb 2, 2000·Plastic and Reconstructive Surgery·D M Wise
Aug 10, 2001·Plastic and Reconstructive Surgery·S Y GieseJ A Yanovski
Nov 17, 2001·Plastic and Reconstructive Surgery·G W CommonsC C Chang
Jul 27, 2002·Plastic and Reconstructive Surgery·Hongshik HanNeil A Fine
Sep 10, 2003·Plastic and Reconstructive Surgery·David L Abramson
Sep 18, 1997·Journal of the American Medical Informatics Association : JAMIA·I J Kalet, M M Austin-Seymour
Dec 16, 2006·IEEE Transactions on Medical Imaging·Ismail B TutarYongmin Kim
Nov 5, 1998·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·M C Redmond

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.